A Novel Rabbit Anti-Myoglobin Monoclonal Antibody’s Potential Application in Rhabdomyolysis Associated Acute Kidney Injury
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24097822 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Xinyue Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Disaster and Emergency Medicine, Medical College, Tianjin University, Tianjin 300072, China. Hauptthemen laut MEDLINE: Rhabdomyolysis, Acute Kidney Injury. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Technology of the People's Republic of China (National Key R&D Pro-gram of China), National Natural Science Foundation of China, Ministry of Science and Technology of the People’s Republic of China.
Abstract (Originalsprache)
Myoglobin (Mb) is the main constituent of vertebrate skeletal muscle and myocardium and plays an essential role in oxygen binding, storage, transport, and earliest disease diagnosis. This study focuses on preparing the novel recombinant rabbit anti-Mb monoclonal antibody and applying it to a diagnosis of Mb deposition in rhabdomyolysis-associated acute kidney injury (RM-AKI). The full-length coding sequence of rat Mb was cloned and expressed, and the high-quality and titer rabbit anti-Mb polyclonal antibodies were produced by the immunogen His-Mb fusion protein. A new hybridoma cell was obtained by hybridoma screening technology. With the help of DNA sequencing and a molecular clonal, anti-Mb monoclonal antibody heavy and light chains expression plasmid was constructed. Finally, the recombinant rabbit anti-Mb monoclonal antibody with extraordinarily high affinity (KD = 1.21 pM) was obtained. Meanwhile, it had broad species reactivity (mouse, rat, human, and horse) and good tissue specificity (skeletal muscle and myocardium). It also had a very good performance in western blotting, immunohistochemistry, and immunofluorescence assay to detect the Mb level in the kidney, myocardium, and skeletal muscle of RM-AKI. This study will be significantly helpful for Mb-associated disease diagnosis, and pathogenesis exploration, and further may act as a neutralizing antibody for disease treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Disaster and Emergency Medicine, Medical College, Tianjin University, Tianjin 300072, China.
- Tianjin Key Laboratory of Disaster Medicine Technology, Tianjin 300072, China.
ORCID-Profile: Ning Li, Yanhua Gong
Förderung
- Ministry of Science and Technology of the People's Republic of China (National Key R&D Pro-gram of China)
- National Natural Science Foundation of China
- Ministry of Science and Technology of the People’s Republic of China
Zitieren
APA
Wang, X., Qiao, O., Han, L., Li, N., & Gong, Y. (2023). A Novel Rabbit Anti-Myoglobin Monoclonal Antibody’s Potential Application in Rhabdomyolysis Associated Acute Kidney Injury. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24097822
Vancouver
Wang X, Qiao O, Han L, Li N, Gong Y. A Novel Rabbit Anti-Myoglobin Monoclonal Antibody’s Potential Application in Rhabdomyolysis Associated Acute Kidney Injury. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24097822
BibTeX
@article{Wang2023,
author = {Wang, Xinyue and Qiao, Ou and Han, Lu and Li, Ning and Gong, Yanhua},
title = {A Novel Rabbit Anti-Myoglobin Monoclonal Antibody’s Potential Application in Rhabdomyolysis Associated Acute Kidney Injury},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24097822}
}
EUVIMED